Position in BDSX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,006,135
+$356,782 QoQ
Shares Held
44,618
-0.4% QoQ
Ownership
0.423%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#18
of 44 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in BDSX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PERKINS CAPITAL MANAGEMENT INC holds $26,693,573 across 9 Diagnostics & Research names. BDSX ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
40,605 | $11,022,227 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
9,700 | $5,106,468 | |
| 3 | VCYT |
Veracyte, Inc.
|
59,958 | $3,521,333 | |
| 4 | PSNL |
Personalis, Inc.
|
239,000 | $3,202,600 | |
| 5 | NEO |
Neogenomics Inc
|
110,040 | $1,605,483 | |
| 6 | BDSX |
Biodesix Inc
This page
|
44,618 | $1,006,135 | |
| 7 | MDXH |
MDxHealth SA
|
1,411,891 | $580,287 | |
| 8 | CSTL |
Castle Biosciences Inc
|
16,140 | $384,939 |
All Filings in BDSX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,006,135 | 44,618 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $649,353 | 44,783 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $304,524 | 44,783 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $397,379 | 52,633 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $298,838 | 1,059,711 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $662,319 | 1,059,711 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,622,122 | 1,060,211 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,290,111 | 724,782 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $634,616 | 414,782 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||